MDX logo

MedX Health Stock Price

Symbol: TSXV:MDXMarket Cap: CA$24.1mCategory: Healthcare

MDX Share Price Performance

MDX Community Fair Values

    Recent MDX News & Updates

    No updates

    MedX Health Corp Key Details

    CA$494.0k

    Revenue

    CA$284.1k

    Cost of Revenue

    CA$210.0k

    Gross Profit

    CA$4.5m

    Other Expenses

    -CA$4.3m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.014
    Gross Margin
    42.50%
    Net Profit Margin
    -875.08%
    Debt/Equity Ratio
    -79.5%

    MedX Health Corp Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About MDX

    Founded
    1999
    Employees
    n/a
    CEO
    Stephen Lockyer
    WebsiteView website
    www.medxhealth.com

    MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also provides scope kits, SIAscope, a clinical camera; and DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.

    Canadian Market Performance

    • 7 Days: 0.02%
    • 3 Months: 11.9%
    • 1 Year: 16.6%
    • Year to Date: 9.6%
    The market has been flat over the last week. As for the longer term, the market has risen 17% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading